Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer
about
Significance of baseline and change in neutrophil-to-lymphocyte ratio in predicting prognosis: a retrospective analysis in advanced pancreatic ductal adenocarcinoma.Neutrophil-to-Lymphocyte Ratio for Predicting Loss of Response to Infliximab in Ulcerative ColitisLoss of Muscle Mass is a Novel Predictor of Postoperative Early Recurrence in N2-Positive Non-Small-Cell Lung Cancer.Comparison of guidelines for intraductal papillary mucinous neoplasm: What is the next step beyond the current guidelines?
P2860
Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pretreatment Neutrophil to Lym ...... III Non-Small Cell Lung Cancer
@ast
Pretreatment Neutrophil to Lym ...... III Non-Small Cell Lung Cancer
@en
type
label
Pretreatment Neutrophil to Lym ...... III Non-Small Cell Lung Cancer
@ast
Pretreatment Neutrophil to Lym ...... III Non-Small Cell Lung Cancer
@en
prefLabel
Pretreatment Neutrophil to Lym ...... III Non-Small Cell Lung Cancer
@ast
Pretreatment Neutrophil to Lym ...... III Non-Small Cell Lung Cancer
@en
P2093
P2860
P1433
P1476
Pretreatment Neutrophil to Lym ...... III Non-Small Cell Lung Cancer
@en
P2093
Baocheng Wang
Bicheng Zhang
Jianhua Hu
Neda Kalhor
Yaping Guan
P2860
P304
P356
10.1371/JOURNAL.PONE.0163397
P407
P577
2016-10-03T00:00:00Z